Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paediatric transfusion.

H V New1

  • 1Department of Paediatrics, St Mary's Hospital, London, UK. helen.new@st-mary.nhs.uk

Vox Sanguinis
|December 20, 2005
PubMed
Summary
This summary is machine-generated.

Pediatric transfusion needs differ from adults, especially for vulnerable neonates facing unique risks and side effects. Long-term impacts are significant for children with good life expectancy, necessitating clear guidelines for blood product use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial.

British journal of haematology·2025
Same author

Transfusion in neonates and older children: Principles and updates.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2019
Same author

Patient blood management, what does this actually mean for neonates and infants?

Transfusion medicine (Oxford, England)·2018
Same author

Exchange transfusion and intravenous immunoglobulin use in the UK.

Archives of disease in childhood. Fetal and neonatal edition·2009
Same author

Neonatal transfusions.

Vox sanguinis·2009
Same author

Antenatal antibody screening.

Lancet (London, England)·2001
Same journal

In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

Vox sanguinis·2026
Same journal

Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

Vox sanguinis·2026
Same journal

Fibrinogen recovery in cryoprecipitate prepared from thawed plasma stored for 5 days post-thaw.

Vox sanguinis·2026
Same journal

Abstracts of the 39th International Congress of the ISBT, Kuala Lumpur, Malaysia, 20-24 June 2026.

Vox sanguinis·2026
Same journal

Development and improvement of Chinese Haemovigilance Network from 2018 to 2023.

Vox sanguinis·2026
Same journal

Marginal anaemia and perioperative transfusion in female patients undergoing cardiac surgery.

Vox sanguinis·2026
See all related articles

Area of Science:

  • Pediatric Transfusion Medicine
  • Neonatal Hematology
  • Blood Product Safety

Background:

  • Children's transfusion requirements are distinct from adults, with neonates being particularly vulnerable.
  • Concerns exist regarding infective/toxic risks and acute side effects in neonates due to their small blood volume.
  • Long-term side effects of transfusions are more significant in children with good life expectancy.

Purpose of the Study:

  • To highlight the distinct needs of pediatric transfusion.
  • To address confusion surrounding neonatal transfusion component specifications and their appropriate use.
  • To underscore the need for evidence-based guidelines in pediatric transfusion.

Main Methods:

  • Review of current transfusion practices and guidelines for children and neonates.

Related Experiment Videos

  • Analysis of existing neonatal transfusion component specifications.
  • Identification of knowledge gaps and areas requiring further research.

    • Main Results:

    • Confusion exists among medical and laboratory staff regarding the appropriate use of neonatal transfusion components.
    • There is a lack of robust evidence underlying many pediatric transfusion guidelines.
    • Trends indicate decreased blood usage in neonates, with ongoing studies investigating optimal use.

    Conclusions:

    • Pediatric transfusion management requires specialized consideration distinct from adult protocols.
    • Clearer guidelines and further research are essential to ensure safe and effective blood product utilization in neonates and children.
    • Addressing evidence gaps will improve transfusion outcomes for pediatric populations.